8-week Pilot Study of Relaxation for Weight Loss in Adults With Chronic Kidney Disease - NCT00944138-60141 (Clinical Trial 303100)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy303100.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Hines |
|
State:
|
|
IL |
| Zip Code: |
|
60141 |
| Conditions: |
|
Obesity |
| Purpose: |
|
Obesity plays a causal role for kidney disease incidence and progression. Moderate weight
loss reduces the high metabolic demands on the kidney and decreases proteinuria in both
diabetic and non-diabetic nephropathies. However, maintaining behavioral changes for weight
loss is very challenging, and common chronic kidney disease (CKD) co-morbidities such as
decreased exercise capacity only compound this difficulty. Moreover, no weight loss
medications have been adequately tested in adults with CKD and most are contraindicated in
this population. Mindful meditation or "mindfulness" in addition to other relaxation
techniques may help adults lose weight by interrupting learned behavior, curbing compulsive
eating, and reducing stress and appetite. Although mindful meditation and other relaxation
techniques have gained the attention of the mainstream media for obesity treatment,
scientific data on its efficacy remain limited. Due to the short duration of this study,
substantial weight loss in any participant is not expected. Instead, the primary purpose of
this study is to examine the feasibility of a randomized controlled trial of mindful
meditation relaxation techniques combined with standard care compared to standard care alone
for the treatment of obesity among Veterans with CKD.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- receive medical care at the Hines VA CKD clinics.
- Presence of chronic kidney disease defined as an estimated glomerular filtration rate
< 60 ml/min/1.73 m2 BSA or a spot urine albumin/creatinine ratio ≥ 30 mg/g
- BMI ≥ 35 kg/m2 or a waist circumference ≥ 102 (40 inches) and ≥ 88 cm (35 inches) in
men and women, respectively.
Exclusion Criteria:
- Inability to give informed consent
- inability to come to VA for two group sessions
- inability to listen to an MP3 player using headphones |
|
|
|
| Study is available at: |
|
Edward Hines, Jr. VA Hospital
Hines, IL 60141
United States
Primary Contact:
Holly Kramer, MD MPH
Email: hkramer@lumc.edu
Phone: 708-202-8387
Secondary Contact:
Holly Kramer, MD MPH
Email: hkramer@lumc.edu
Phone: 7083279039 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|